2,078
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis

, , , , , , & ORCID Icon show all
Pages 5373-5385 | Received 25 May 2021, Accepted 21 Jul 2021, Published online: 01 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Habib Haybar, Narjes Sadat Sadati, Daryush Purrahman, Mohammad Reza Mahmoudian-Sani & Najmaldin Saki. (2023) lncRNA TUG1 as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases. Epigenomics 15:23, pages 1273-1290.
Read now
Yan Chen, Zewen Liu, Zhengqing Hu, Xiuyuan Feng & Li Zuo. (2022) Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways. Bioengineered 13:4, pages 8321-8331.
Read now
Guizhi Jia, Chunguang Liang, Wenhui Li & Hongliang Dai. (2022) MiR-410-3p facilitates Angiotensin II–induced cardiac hypertrophy by targeting Smad7. Bioengineered 13:1, pages 119-127.
Read now

Articles from other publishers (13)

Lei Zhang, Xin Li, Huijuan Gao & Peifeng Li. (2024) The Role of Circular RNA Variants Generated from the NFIX Gene in Different Diseases . Molecular Pharmaceutics 21:3, pages 1027-1037.
Crossref
Natalia M. Baulina, Ivan S. Kiselev, Olga S. Chumakova & Olga O. Favorova. (2024) Circular RNAs: Biogenesis, Functions, and Role in Myocardial Hypertrophy. Biochemistry (Moscow) 89:S1, pages S1-S13.
Crossref
Kaidi Wu & Jiawei Du. (2023) Knockdown of circSlc8a1 inhibited the ferroptosis in the angiotensin II treated H9c2 cells via miR-673-5p/TFRC axis. Journal of Bioenergetics and Biomembranes.
Crossref
Parsa Hoque, Brigette Romero, Robert E Akins & Mona Batish. (2023) Exploring the Multifaceted Biologically Relevant Roles of circRNAs: From Regulation, Translation to Biomarkers. Cells 12:24, pages 2813.
Crossref
Haoteng Ke, Zexing Chen, Xuanbin Zhao, Chaobo Yang, Tao Luo, Wen Ou, Lizi Wang & Haiqiong Liu. (2023) Research progress on activation transcription factor 3: A promising cardioprotective molecule. Life Sciences 328, pages 121869.
Crossref
Rui Song, Ting Chai, Junqi Liu, Alan Chu, Chen Sun & Zongwen Liu. (2023) Knockdown of circMFN2 inhibits cell progression and glycolysis by miR‐198/CUL4B pathway in ovarian cancer. Journal of Biochemical and Molecular Toxicology 37:8.
Crossref
Desh Deepak Singh, Youngsun Kim, Seung Ah Choi, Ihn Han & Dharmendra Kumar Yadav. (2023) Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases. Cells 12:12, pages 1629.
Crossref
Chen Ding & Yafeng Zhou. (2023) Insights into circular RNAs : Biogenesis, function and their regulatory roles in cardiovascular disease . Journal of Cellular and Molecular Medicine 27:10, pages 1299-1314.
Crossref
Vanessa Ribeiro, Susana G. Martins, Ana Sofia Lopes, Sólveig Thorsteinsdóttir, Rita Zilhão & Ana Rita Carlos. (2023) NFIXing Cancer: The Role of NFIX in Oxidative Stress Response and Cell Fate. International Journal of Molecular Sciences 24:5, pages 4293.
Crossref
Kaihao Wang, Min Zhou, Youhong Zhang, Yipeng Du, Peixin Li, Chang Guan & Zheng Huang. (2023) IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli. International Journal of Cardiology 371, pages 332-344.
Crossref
Gang Zhou, Hui Wu, Di Liu, Yunzhao Li & Dong Zhang. (2022) MicroRNA-145-5p in cardiovascular disease: An insufficiently explored and controversial research area. International Journal of Cardiology 366, pages 30.
Crossref
Yu Zhang, Heming Wu, Honghui Luo, Yiqun Luo & Cong Huang. (2022) Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61. Molecular Medicine Reports 26:5.
Crossref
Joana Silva & Paula A. da Costa Martins. (2022) Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy. Cells 11:11, pages 1805.
Crossref